drugset / Trial / NCT06411912
A Study of NIDO-361 in Patients With SBMA
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and efficacy of NIDO-361 in adult patients with Spinal and Bulbar Muscular Atrophy (SBMA).
Timeline
- Start
- 2024-03-01
- Primary completion
- 2025-10-22
- Completion
- 2025-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NIDO-361 | Unknown | 200 mg | Oral |